Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington State University
About this trial
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.
Eligibility criteria
Qualifiers
4 or more standard drinks on the same occasion for women (5 or more standard drinks on the same occasion for men) on at least 4 occasions in the prior 30 days
Seeking AUD treatment
Seeking smoking cessation treatment
Aged 18+ years
Disqualifiers
Significant risk of dangerous alcohol withdrawal, defined as a history of alcohol detoxification or seizure in the last 12 months and expression of concern by the participant about dangerous withdrawal
Currently receiving any pharmacotherapy for alcohol
Currently receiving any pharmacotherapy for smoking
No suicide attempt in the last 20 years and
Trial design
Treatments tested in this trial
- Contingency Management
- Non-contingent control
Treatment groups
205 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov